trial · primary record
Nipocalimab
Hemolytic Disease of the Fetus and Newborn
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2029-10-08 |
| Primary endpoint | Percentage of Pregnancies That did not Result in Fetal Loss, Intrauterine Transfusion (IUT), Hydrops Fetalis, or Neonatal Death |
| Registry ID | NCT05912517 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:53.371Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05912517
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nipocalimab · compound